Aparici M, Fernández González A L, Alegría E
Departamento de Cardiología y Cirugía Cardiovascular, Clínica Universitaria de Navarra, Pamplona.
Rev Clin Esp. 1994 Jun;194(6):453-6.
The objective of our work was to carry out a prospective study on the effectiveness of clonidine and nicotine gum in the treatment of tobacco withdrawal. Sixty smokers were randomly distributed in two groups and were included in a tobacco withdrawal program. One group received oral clonidine treatment while the other group was given nicotine gum. Adjuvant therapy such as group therapy or psychotherapy was not performed. At the end of one year there were no significant differences between the two groups with regards to the number of subjects who have continued to stop smoking. There were also no significant differences between the two groups with regards to the symptoms of tobacco abstinence. When we studied the relation between treatment fulfillment and tobacco withdrawal we observed that the clonidine treated group had a significantly greater number of success compared to the nicotine group (p < 0.01).
我们这项工作的目的是对可乐定和尼古丁口香糖治疗戒烟的有效性进行一项前瞻性研究。60名吸烟者被随机分为两组,并纳入一个戒烟项目。一组接受可乐定口服治疗,而另一组则给予尼古丁口香糖。未进行如团体治疗或心理治疗等辅助治疗。一年结束时,在继续戒烟的受试者数量方面,两组之间没有显著差异。在戒烟症状方面,两组之间也没有显著差异。当我们研究治疗依从性与戒烟之间的关系时,我们观察到与尼古丁组相比,可乐定治疗组的成功人数显著更多(p < 0.01)。